Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • RIGEL PHARMACEUTICALS INC Financial Overview

  • Income Statement: RIGL

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 0.00 12.60 M -12.60 M -∞ T%
    Gross Profit -109.67 M -57.76 M -51.91 M 47.33%
    Net Income Before Extra Items/Preferred Div -132.35 M -74.27 M -58.07 M 43.88%
    Operating Income -136.71 M -79.53 M -57.19 M 41.83%
  • Cash Flow: RIGL

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing 131.99 M 56.78 M 75.21 M 56.98%
    Net Cash Flow - Investing 26.97 M 7.79 M 19.18 M 71.10%
    Net Cash Flow/Operating Activities -103.52 M -52.21 M -51.31 M 49.57%
  • Balance Sheet: RIGL

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 143.86 M 115.79 M 28.07 M 19.51%
    Total Liabilities 39.69 M 33.61 M 6.09 M 15.33%
    Shareholders Equity 104.16 M 82.18 M 21.98 M 21.10%
  • Key Ratios / Statistics: RIGL

    • Valuation

      Price/Earnings (TTM) -2.18
      Price/Sales (TTM) 58.31
      Price/Book (MRQ) 8.65
      Price/Cash Flow (TTM) -2.11
    • Profitability

      Gross Margin -458.44
      Operating Margin -631.17
      Profit Margin -589.46
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 5.57
      Current Ratio (MRQ) 4.23
      Long Term Debt-to-Equity (MRQ) 2.78
    • Management Effectiveness

      Return on Equity (TTM) -134.40
      Return on Assets (TTM) -92.42
      Return on Investments (TTM) -138.10